June 19, 2009: Aurgalys-CLS initiates analyst coverage of BioAlliance Pharma [Euronext: BIO]
juin 19, 2009
BioAlliance Pharma is a biopharmaceutical company which develops and markets innovative therapeutics addressing unmet medical needs in the treatment and supportive care of life threatening diseases including cancer and AIDS
Download our BioAlliance Coverage here (available in english only)